Medtech company commercializing a revolutionary cardiac assist device: biventricular and without blood-contact
Adjucor has raised €29M across 1 funding round from 2 investors, most recently a Series B round in Jun 2021. Based in Munich, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-06-14 | Series B | €29M |
| Maurizio Capital,MitrAssist |
| View deal → |
